Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Capecitabine × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 36 Stomach Neoplasms 17 Rectal Neoplasms 14 Colorectal Neoplasms 13 Triple Negative Breast Neoplasms 10 Neoplasm Metastasis 10 Adenocarcinoma Of Esophagus 7 Esophageal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Nasopharyngeal Carcinoma 5 Colonic Neoplasms 5 Adenocarcinoma 5 Recurrence 4 Neoplasms 4 Cholangiocarcinoma 4 Locally Advanced Rectal Cancer 3 Colorectal Cancer Metastatic 3 Brain Neoplasms 3 Anus Neoplasms 3 Somatostatinoma 2 Pathologic Complete Response 2 HER2-positive Gastric Cancer 2 Gallbladder Neoplasms 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Advanced Solid Tumour 2 Solid Cancer 1 Resectable Colon Cancer 1 Rectal Neoplasms Malignant 1 Pancreatic Neoplasms 1

Interventions

Nivolumab 8 pembrolizumab 7 avelumab 5 Specimen Handling 5 Biopsy 5 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 cemiplimab 2 atezolizumab 2 aldesleukin 2 Radiotherapy 2 Immunoglobulin G 2 Cyclophosphamide 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 durvalumab 1 deltacortene 1 decitabine and cedazuridine drug combination 1 aflibercept 1 X-Rays 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡